The investigators proposed to discover, through computation, lead compounds in the development of anti-AIDS drugs. Specific systems include HIV reverse transcriptase and HIV integrase. In addition, the investigators will attempt to refine their existing leads for HIV reverse transcriptase, HIV-integrase and HIV-RNA/TAR using DOCK and molecular dynamics-based methods coupled with structures if drug- receptor complexes. Aid will be provided to develop third generation versions of dominant negative strategy against HIV protease. Computational tools available for drug discovery and drug design will be developed and improved, with emphasis on speed enhancements, conformational searching, improved energy calculations combinatorial calculations, and anti-resistance strategies. Focus will be on an integrated approach to intensive optimization of the most important molecules using the following steps: (a) Aqvisits Linear Interaction Analysis (LIA) Method to suggest the most promising templates and the most favorable location of these templates in the macromolecule site; (b) Radmer's PROFEC methods coupled with the fragment and geometric search features of BUILDER, to suggest template modifications to improve binding; (c) Continued development of free energy calculations on a collection of the most promising substitutes of the most promising templates.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Program Projects (P01)
Project #
5P01GM056531-04
Application #
6347557
Study Section
Project Start
2000-09-01
Project End
2001-08-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
4
Fiscal Year
2000
Total Cost
$270,826
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Ohol, Yamini M; Goetz, David H; Chan, Kaman et al. (2010) Mycobacterium tuberculosis MycP1 protease plays a dual role in regulation of ESX-1 secretion and virulence. Cell Host Microbe 7:210-20
Lang, P Therese; Brozell, Scott R; Mukherjee, Sudipto et al. (2009) DOCK 6: combining techniques to model RNA-small molecule complexes. RNA 15:1219-30
Lim, Mark D; Craik, Charles S (2009) Using specificity to strategically target proteases. Bioorg Med Chem 17:1094-100
Daugherty, Matthew D; D'Orso, Ivan; Frankel, Alan D (2008) A solution to limited genomic capacity: using adaptable binding surfaces to assemble the functional HIV Rev oligomer on RNA. Mol Cell 31:824-34
Graves, Alan P; Shivakumar, Devleena M; Boyce, Sarah E et al. (2008) Rescoring docking hit lists for model cavity sites: predictions and experimental testing. J Mol Biol 377:914-34
Raorane, Digvijay A; Lim, Mark D; Chen, Fanqing Frank et al. (2008) Quantitative and label-free technique for measuring protease activity and inhibition using a microfluidic cantilever array. Nano Lett 8:2968-74
He, Xin; Alian, Akram; Ortiz de Montellano, Paul R (2007) Inhibition of the Mycobacterium tuberculosis enoyl acyl carrier protein reductase InhA by arylamides. Bioorg Med Chem 15:6649-58
Lazic, Ana; Goetz, David H; Nomura, Anson M et al. (2007) Substrate modulation of enzyme activity in the herpesvirus protease family. J Mol Biol 373:913-23
Mills, Nicholas L; Shelat, Anang A; Guy, R Kiplin (2007) Assay Optimization and Screening of RNA-Protein Interactions by AlphaScreen. J Biomol Screen 12:946-55
Huang, Niu; Jacobson, Matthew P (2007) Physics-based methods for studying protein-ligand interactions. Curr Opin Drug Discov Devel 10:325-31

Showing the most recent 10 out of 80 publications